biotech · Ataxia Telangiectasia · Ataxia Telangiectasia (A-T) · QNCX
Quince Therapeutics
Quince Therapeutics trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
South San Francisco, USA HQ
2012 Founded
21 Employees
Public company Type
QNCX · NYSE Ticker
Company details
- Status
- Public
- HQ
- South San Francisco, USA
- Founded
- 2012
- Employees
- 21
- Programs
- 10
- Drugs
- 8
- Patents
- 1
Quince Therapeutics clinical trials
Registry index of 11 ClinicalTrials.gov studies linked to Quince Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Quince Therapeutics trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Quince Therapeutics.
-
IEDAT-04-2022 — Phase 3
Clinical update -
DSP loaded RBC using EryDex System — Phase 1
Clinical update -
Dex 21-P — Phase 2
Clinical update -
EryDex Low dose DSP — Phase 3
Clinical update -
Dexamethasone sodium phosphate for encapsulation into autoerythrocytes — Phase 3
Clinical update -
Dexamethasone — Phase 3
Clinical update -
Dexamethasone sodium phosphate — Phase 3
Clinical update -
EryDex System — Phase 3
Clinical update